retatrutide peptide amazon (RETA-40) 107mg Research RETATRUTIDE (RETA) – Research Peptide

In major studies, adults with obesity (without diabetes) who took the daily oral formulation achieved an average weight loss of approximately 15% to 17% of their body weight over 68 weeks

The result is a drug that reduces LDL by up to 60% on top of existing therapy and cuts the risk of heart attack and stroke in ways statins alone cant achieve

doi: 10.1016/j.celrep.2020.108487 66 DAmicoDAndreuxPAValdesPSinghARinschCAuwerxJ

Interesting distinction

Synergy of Triple Agonism The simultaneous action on these three receptors achieves effects not observed with single- or dual-receptor agonists: Greater weight reduction, driven by combined appetite suppression (GLP-1, GIP) and increased energy expenditure (glucagon) 1

Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: A randomized controlled trial